Over the past decade, several large pharmaceutical companies have either closed their doors in Connecticut or cut hundreds of jobs from their local payrolls. These moves pose a threat to the state economy. For Connecticut to thrive in the future, say state political, academic and business leaders, more jobs are needed in groundbreaking biomedical research and a home-grown biotech industry.

The 10-year-old Yale Stem Cell Center, which is within Yale School of Medicine, is an example of how this can be done. It has already created more than 200 jobs; involves more than 450 Yale faculty, post-docs and students; has produced more than 350 patent applications; and has three therapies currently being tested in clinical trials.